Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Canioni

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
The New England Journal of Medicine|September 28, 2017
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell LymphomaSteven Le Gouill, Catherine Thieblemont, Lucie Oberic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2016
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA StudySydney Dubois, Pierre-Julien Viailly, Sylvain Mareschal, et al.
Blood|December 2, 2010
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)Jana Pachlopnik Schmid, Danielle Canioni, Despina Moshous, et al.
American Journal of Hematology|April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot studyJosquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 30, 2024
Histological characterization of liver involvement in systemic mastocytosisJulien Rossignol, Danielle Canioni, Achille Aouba, et al.
The Journal of Allergy and Clinical Immunology|August 26, 2023
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypesLaura Polivka, Marine Madrange, Cristina Bulai-Livideanu, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
The New England Journal of Medicine|September 28, 2017
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell LymphomaSteven Le Gouill, Catherine Thieblemont, Lucie Oberic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2016
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA StudySydney Dubois, Pierre-Julien Viailly, Sylvain Mareschal, et al.
Blood|December 2, 2010
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)Jana Pachlopnik Schmid, Danielle Canioni, Despina Moshous, et al.
American Journal of Hematology|April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot studyJosquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 30, 2024
Histological characterization of liver involvement in systemic mastocytosisJulien Rossignol, Danielle Canioni, Achille Aouba, et al.
The Journal of Allergy and Clinical Immunology|August 26, 2023
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypesLaura Polivka, Marine Madrange, Cristina Bulai-Livideanu, et al.
Pageof 10